TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Osteopore Ltd. ( (AU:OSX) ) is now available.
Osteopore Limited has reported significant progress following its Exclusive Distribution Agreement with Zimmer Biomet, a global medical technology leader. Over the first 12 months of the partnership, sales of Osteopore’s craniofacial products in Europe, Australia, and Hong Kong have tripled compared to the previous year. This growth highlights the company’s resilience in manufacturing and its ability to scale operations effectively. With recent European approval for custom-made cranioplasty implants, Osteopore anticipates increased market traction and plans to expand into new markets in collaboration with Zimmer Biomet.
More about Osteopore Ltd.
Osteopore Limited is an Australian-Singaporean regenerative medicine company specializing in 3D-printed biomimetic and bioresorbable implants. The company is recognized as a global leader in its field, focusing on innovative medical solutions for craniofacial applications.
Average Trading Volume: 2,317,970
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$2.59M
See more insights into OSX stock on TipRanks’ Stock Analysis page.